Evidence map›Paper›PMID 31843395›Full record

ArticleExperimental gerontology2020

Loss of NRF2 leads to impaired mitochondrial function, decreased synaptic density and exacerbated age-related cognitive deficits.

Jonathan A Zweig, Maya Caruso, Mikah S Brandes, Nora E Gray

Open access · greenAbstract read
In one paragraph

Article in Experimental gerontology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Phytochemical Profiling and Anti-Obesogenic Potential ofMolecules (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. The Emerging Role of Brain Mitochondria in Fear and Anxiety.Current topics in behavioral neurosciences · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. The Interaction ofCells · 2022
    Review
  18. Article
  19. Antioxidants (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jonathan A ZweigDepartment of Neurology, Oregon Health and Science University, Portland, OR 97239, USA.
Maya CarusoDepartment of Neurology, Oregon Health and Science University, Portland, OR 97239, USA.
Mikah S BrandesDepartment of Neurology, Oregon Health and Science University, Portland, OR 97239, USA.
Nora E GrayDepartment of Neurology, Oregon Health and Science University, Portland, OR 97239, USA. Electronic address: grayn@ohsu.edu.
Oregon Health & Science University · US

Funding

EXITO: Enhancing Cross-disciplinary Infrastructure and Training at OregonUL1GM118964 · NIGMS · PORTLAND STATE UNIVERSITY · PI KELLER, THOMAS E · 2015 to 2023
$18.0M
EXITO: Enhancing Cross-disciplinary Infrastructure and Training at OregonRL5GM118963 · NIGMS · PORTLAND STATE UNIVERSITY · PI KELLER, THOMAS E · 2015 to 2023
$11.9M
EXITO: Enhancing Cross-disciplinary Infrastructure and Training at OregonTL4GM118965 · NIGMS · PORTLAND STATE UNIVERSITY · PI KELLER, THOMAS E · 2015 to 2022
$10.1M
CAM Research Training in Neuroscience &StressT32AT002688 · NCCIH · OREGON HEALTH & SCIENCE UNIVERSITY · PI OKEN, BARRY S, SOUMYANATH, AMALA · 2005 to 2025
$7.2M
Mechanisms and active compounds in the cognitive effects of Centella asiaticaR01AT008099 · NCCIH · OREGON HEALTH & SCIENCE UNIVERSITY · PI SOUMYANATH, AMALA · 2014 to 2018
$2.2M
Mitochondrial, antioxidant and cognitive effects of Centella asiatica during agingR00AT008831 · NCCIH · OREGON HEALTH & SCIENCE UNIVERSITY · PI GRAY, NORA · 2017 to 2019
$726k
A novel estrogen modulator for the treatment of Alzheimer's diseaseI01BX003440 · VA · PORTLAND VA MEDICAL CENTER · PI QUINN, JOSEPH F · 2018 to 2021
–
BLRD VA I01 BX003440NCCIH NIH HHS R00 AT008831NCCIH NIH HHS R01 AT008099NCCIH NIH HHS T32 AT002688NIGMS NIH HHS RL5 GM118963NIGMS NIH HHS TL4 GM118965NIGMS NIH HHS UL1 GM118964
6 · The paper itself

Abstract

Activation of the antioxidant regulatory transcription factor NRF2 (Nuclear factor erythroid-derived 2) regulates cellular bioenergetics and improves neuronal health in aging. Yet how NRF2 participates in maintaining synaptic, mitochondrial and cognitive function has not been fully elucidated. This study investigates how loss of NRF2 affects neuronal metabolism, synaptic density and cognitive performance in aged mice. Dendritic arborization as well as synaptic and mitochondrial gene expression was evaluated in hippocampal neurons isolated from mice lacking NRF2 (NRF2KO) and from wild-type (WT) C57BL6 mice. Mitochondrial function of these neurons was evaluated using the Seahorse XF platform. Additionally learning, memory and executive function were assessed in 20 month old NRF2KO and age-matched WT mice using conditioned fear response (CFR) and odor discrimination reversal learning (ODRL) tests. Hippocampal bioenergetics was profiled using mitochondria isolated from these animals and tissue was harvested for assessment of mitochondrial and synaptic genes. NRF2KO neurons had reduced dendritic complexity and diminished synaptic gene expression. This was accompanied by impaired mitochondrial function and decreased mitochondrial gene expression. Similar mitochondrial deficits were observed in the brains of aged NRF2KO mice. These animals also had significantly impaired cognitive performance and reduced synaptic gene expression as well. These data point to a role for NRF2 in maintaining mitochondrial and cognitive function during aging and suggest that the transcription factor may be a viable target for cognitive enhancing interventions. Because mitochondrial dysfunction and cognitive impairment also occur together in many neurodegenerative conditions there may be broad therapeutic potential of NRF2 activating agents.

Indexed as

AgingAnimalsAntioxidantsBrainCognitionCognitive DysfunctionExecutive FunctionFemaleLearningMaleMemoryMiceMice, Inbred C57BLMice, KnockoutMitochondriaNeuronsAntioxidantsNF-E2-Related Factor 2AgingCognitionMitochondrial functionNRF2

Identifiers

PMID31843395
PMCPMC6953739
OpenAlexW2995328632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.